LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification
78 p.
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/47461 |
| _version_ | 1826112629856272384 |
|---|---|
| author | Laleh Sadrolodabaee |
| author2 | Chen Wei Ning, William |
| author_facet | Chen Wei Ning, William Laleh Sadrolodabaee |
| author_sort | Laleh Sadrolodabaee |
| collection | NTU |
| description | 78 p. |
| first_indexed | 2024-10-01T03:10:15Z |
| format | Thesis |
| id | ntu-10356/47461 |
| institution | Nanyang Technological University |
| last_indexed | 2024-10-01T03:10:15Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | ntu-10356/474612023-03-03T15:58:12Z LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification Laleh Sadrolodabaee Chen Wei Ning, William School of Chemical and Biomedical Engineering DRNTU::Science::Medicine::Pharmacy::Pharmaceutical technology 78 p. Warfarin is considered as one of the most common anticoagulation drugs in the world. However, Because of wide dosage variation in different patients, lack of wide therapeutic index and risk for bleeding complications, treatment with this drug must be done very wisely. MASTER OF ENGINEERING (SCBE) 2011-12-27T08:22:31Z 2011-12-27T08:22:31Z 2009 2009 Thesis Laleh, S. (2009). LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment: potential in biomarker identification. Master’s thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/47461 10.32657/10356/47461 Nanyang Technological University application/pdf |
| spellingShingle | DRNTU::Science::Medicine::Pharmacy::Pharmaceutical technology Laleh Sadrolodabaee LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title | LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title_full | LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title_fullStr | LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title_full_unstemmed | LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title_short | LC-MS/MS analysis of drug dosage and genetic polymorphism in patients on anti-coagulant warfarin treatment : potential in biomarker identification |
| title_sort | lc ms ms analysis of drug dosage and genetic polymorphism in patients on anti coagulant warfarin treatment potential in biomarker identification |
| topic | DRNTU::Science::Medicine::Pharmacy::Pharmaceutical technology |
| url | https://hdl.handle.net/10356/47461 |
| work_keys_str_mv | AT lalehsadrolodabaee lcmsmsanalysisofdrugdosageandgeneticpolymorphisminpatientsonanticoagulantwarfarintreatmentpotentialinbiomarkeridentification |